i
Demographics of patients receiving TPOXX for treatment of monkeypox
-
August 31, 2022
Details:
-
Corporate Authors:
-
Description:Updated August 31, 2022
CDC, in partnership with FDA, has made it easier for healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under an expanded access Investigational New Drug (EA-IND) protocol. As of August 29, 2022, CDC has received and abstracted data from forms submitted on 1001 patients. However, this number underestimates the number of patients who are receiving TPOXX treatment as healthcare providers can start treatment before submitting IND paperwork to CDC. The table below shows the demographics of these 1001 patients who have received TPOXX and whose data have been analyzed.
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: